6-(4-Phenyl-benzyloxy-methyl) guvacine. Synthesis, GABA uptake inhibitor and muscarinic properties

Bioorganic and Medicinal Chemistry Letters

Volumn 6, Issue 24, 1996, Pages 3025-3028

  Bisel, Philippe ^a   Gies, Jean Pierre ^b   Schlewer, Gilbert ^a   Wermuth, Camille G ^a  

^a Laboratoire de Pharmacochimie   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4,4 DIPHENYL 3 BUTENYL)GUVACINE; 6 (4 PHENYLBENZYLOXYMETHYL)GUVACINE; GUVACINE; GUVACINE DERIVATIVE; METHYLSCOPOLAMINE; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; PIRENZEPINE; UNCLASSIFIED DRUG;

4 AMINOBUTYRIC ACID UPTAKE; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DESIGN; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; NONHUMAN;

EID: 0030591864     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(96)00562-8     Document Type: Article

References (19)

1. 1. Johnston, G.A.R.; Krogsgaard-Larsen, P.; Stephanson, A. Nature, 1975; 258; 627-628.
2. 2. Frey, H.-H.; Popp, C.; Löscher, W. Neuropharmacology, 1979; 18; 581-590.
3. 3. Ali, F.E.; Bondinell, W.E.; Dandrige, P.A.; Frazee, J.S.; Garvey, E.; Girard, G.R.; Kaiser, C.; Ku, T.W.; Lafferty, J.J.; Moonsammy, G.I.; Oh, H.J.; Venslavsky, J.W.; Volpe, B.W.; Yunger, L.M.; Zircle, C.L. J. Med. Chem., 1985; 28; 653-660.
4. 4. Yunger, L.M.; Fowler, P.J.; Zarevics, P.; Setler, P.E. J. Pharmacol.Exp.Ther., 1984; 228; 109-115
5. 5. Falch, E.; Krogsgaard-Larsen, P. Eur. J. Med. Chem., 1991; 26; 69-78
6. 6. Lapuyade, G.; Schlewer, G.; Wermuth, C.G. Bull. Soc. Chim., 1986; ; 663-668.
7. 7. Lapuyade, G.; Schlewer, G.; N'Goka, V.; Vernières, J.C.; Chambon, J.-P.; Lagrange, J.; Lagrange, P.; Wermuth, C.G. Eur. J. Med. Chem., 1987; 22; 383-391.
8. 8. N'Goka, V.; Schlewer, G.; Linget, J.-M.; Chambon, J.; Wermuth, C.G. J. Med. Chem., 1991; 34; 2547-2557.
9. 9. Pavia, M.R.; Lobbestrel, S.J.; Nugiel, D.; Mayhugh, D.R.; Gregor, V.E.; Taylor, C.P.; Schwarz, R.D.; Brahce, L.; Vartanian, M.G. J. Med. Chem., 1992; 35; 4238-4248.
10. 10. Blorge, S.; Black, A.; Bockbrader, H.; Chang, T.; Gregor, V.E.; Lobbestael, S.J.; Nugiel, D.; Pavia, M.R.; L., R.; Woolf, T. Drug Dev. Res., 1990; 21; 189-193.
11. 11. Bisel, P. Thèse de doctorat de l'Université de Strasbourg I, Université Louis Pasteur, Strasbourg, France, 21 décembre 1993.
12. 12. Matsumoto, I.; Yoshizawa, J. Chem. Abs. 1973; 79; 31912j.
13. 13. Schenker, K.; Druey, J. Helv. Chem. Acta 1959; 42; 1960-1970.
14. 14. Olofson, R.A.; Martz, J.T.; Senet, J.P.; Piteau, M.; Malfroot, T. J. Org. Chem. 1984; 49; 2081-2082.
15. 15. Enna, S.J.; Snyder, S.H. Brain Res., 1975; 100; 81-97.
16. 16. Gies, J.P.; Bertrand, C.; Vanderheyden, P.; Waeldele, F.; Dumont, P.; Pauli, G.; Landry, Y. J. Pharmacol. Exp. Ther. 1989; 250; 309.
17. 17. Haddad, E.B.; Landry, Y.; Gies, J.P. Mol. Parmacol., 1990; 37; 682-688
18. 18. Moser, V.; Lambrecht, G.; Mutschler, E.. Arch. Pharm., 1983; 316; 670-677.
19. 19. Zorn, S.H.; Duman, R.S.; Giachetti, A.; Michelotti, R.; Giraldo, E.; Krogsgaard-Larsen, P.; Enna, S.J. J. Pharmacol. Exp. Ther., 1987; 242; 173-178.